WST West Pharmaceutical Services, Inc.
WST West Pharmaceutical Services, Inc.
Healthcare · Medical Instruments & Supplies
Desk view
Market read
POC $241.89 · VWAP $295.99 · +32.5% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
WST Price Structure
Loading timeframes…
Peers
Every watchlist WST belongs to, members best 30-day change first — WST highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@trace-glp1-manufacturing
Reported the quarter ending 2026-06-30: revenue $872M, diluted EPS $2.15, net income $154M (SEC filing). Across the print the stock moved -8.4% (close before → first close after).
full note →Against street estimates
How WST's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about WST from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 23
- West Pharmaceutical Services, Inc. (WST) Stock Price, News, Quote & History - Yahoo Finance
- West Pharmaceutical Services | WST - Stock Price | Live Quote | Historical Chart
- West Pharmaceutical Services, Inc. (WST) Latest Stock News & Headlines - Yahoo Finance
- West Pharmaceutical Services, Inc. News and Press Releases | PR Newswire
- West Reports Second Quarter 2026 Results 302832704
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
WST research tape
54 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.